Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
388 studies found for:    PROSTATIC HYPERPLASIA, BENIGN
Show Display Options
Rank Status Study
1 Recruiting Prostate Embolization for Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Procedure: Prostatic Embolization;   Drug: Embosphere® Microspheres
2 Completed PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate
Condition: Benign Prostatic Hyperplasia
Interventions: Device: GreenLight HPS (TM)laser system [Photoselective Vaporization of the prostate (PVP)];   Procedure: Transurethral resection of the prostate
3 Unknown  An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL
Condition: Benign Prostatic Hyperplasia
Intervention:
4 Completed
Has Results
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Silodosin;   Other: Placebo
5 Completed
Has Results
The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Silodosin
6 Completed
Has Results
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride;   Drug: Placebo
7 Recruiting Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Embozene Microspheres
8 Completed
Has Results
Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Tadalafil;   Drug: Placebo
9 Completed
Has Results
Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Interventions: Drug: Adherent with 5-alpha-reductase inhibitor (5ARI) therapy;   Drug: Non-adherent to 5ARI therapy
10 Completed Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Silodosin
11 Completed
Has Results
A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)
Condition: Prostatic Hyperplasia
Intervention: Drug: Doxazosin mesylate GITS
12 Unknown  A Study Comparing Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Device: GreenLight XPS vs. TURP
13 Completed
Has Results
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Drug: Silodosin;   Other: Placebo
14 Completed Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Doxazosin
15 Terminated
Has Results
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
16 Completed Saw Palmetto Extract in Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Saw Palmetto
17 Terminated Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Lonidamine
18 Completed Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention:
19 Active, not recruiting Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride 0.5mg capsules;   Drug: Dutasteride placebo capsules;   Drug: Tamsulosin 0.2mg tablets;   Drug: Disintegrating placebo tamsulosin tablet
20 Completed Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Levitra (Vardenafil, BAY38-9456);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.